PEAK6’s Recursion Pharmaceuticals RXRX Stock Holding History

PEAK6’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$602K	Buy	163,900 +13,900	+9%	+$46.3K	﹤0.01%	1894
2026 Q1	$461K	Sell	150,000 -1,482,000	-91%	-$5.73M	﹤0.01%	2011
2025 Q4	$6.67M	Buy	1,632,000 +396,000	+32%	+$1.96M	0.01%	814
2025 Q3	$6.03M	Sell	1,236,000 -212,800	-15%	-$1.12M	0.01%	928
2025 Q2	$7.33M	Buy	1,448,800 +1,377,700	+1,938%	+$6.77M	0.01%	774
2025 Q1	$376K	Buy	+71,100	New	+$518K	﹤0.01%	2186

Other funds holding RXRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

PEAK6's RXRX Position: Q2 2026 in Review

PEAK6 opened a new position in Recursion Pharmaceuticals (RXRX) in Q2 2026: 220,000 shares worth $807K. The stake represents ﹤0.01% of the portfolio and ranks #1782 among its holdings.

343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

PEAK6 held 220,000 shares of Recursion Pharmaceuticals worth $807K as of Q2 2026.
Recursion Pharmaceuticals was a new PEAK6 position in Q2 2026.
Recursion Pharmaceuticals made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #1782 holding.
343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.